Lucchese Marcello, Borisenko Oleg, Mantovani Lorenzo Giovanni, Cortesi Paolo Angelo, Cesana Giancarlo, Adam Daniel, Burdukova Elisabeth, Lukyanov Vasily, Di Lorenzo Nicola
Bariatric, General Surgery and Metabolic Department, Santa Maria Nuova Hospital, Florence, Italy.
Obes Facts. 2017;10(3):261-272. doi: 10.1159/000475842. Epub 2017 Jun 10.
To evaluate the cost-effectiveness of bariatric surgery in Italy from a third-party payer perspective over a medium-term (10 years) and a long-term (lifetime) horizon.
A state-transition Markov model was developed, in which patients may experience surgery, post-surgery complications, diabetes mellitus type 2, cardiovascular diseases or die. Transition probabilities, costs, and utilities were obtained from the Italian and international literature. Three types of surgeries were considered: gastric bypass, sleeve gastrectomy, and adjustable gastric banding. A base-case analysis was performed for the population, the characteristics of which were obtained from surgery candidates in Italy.
In the base-case analysis, over 10 years, bariatric surgery led to cost increment of EUR 2,661 and generated additional 1.1 quality-adjusted life years (QALYs). Over a lifetime, surgery led to savings of EUR 8,649, additional 0.5 life years and 3.2 QALYs. Bariatric surgery was cost-effective at 10 years with an incremental cost-effectiveness ratio of EUR 2,412/QALY and dominant over conservative management over a lifetime.
In a comprehensive decision analytic model, a current mix of surgical methods for bariatric surgery was cost-effective at 10 years and cost-saving over the lifetime of the Italian patient cohort considered in this analysis.
从中期(10年)和长期(终身)的角度,从第三方支付者的视角评估意大利减肥手术的成本效益。
建立了一个状态转换马尔可夫模型,在该模型中患者可能经历手术、术后并发症、2型糖尿病、心血管疾病或死亡。转移概率、成本和效用值取自意大利及国际文献。考虑了三种手术类型:胃旁路手术、袖状胃切除术和可调节胃束带术。对总体人群进行了基础病例分析,其特征取自意大利的手术候选者。
在基础病例分析中,10年间,减肥手术导致成本增加2661欧元,并产生了额外的1.1个质量调整生命年(QALY)。终身来看,手术带来了8649欧元的节省、额外的0.5个生命年和3.2个QALY。减肥手术在10年时具有成本效益,增量成本效益比为2412欧元/QALY,并且在终身范围内优于保守治疗。
在一个全面的决策分析模型中,当前减肥手术的手术方法组合在10年时具有成本效益,并且在本分析中所考虑的意大利患者队列的终身范围内节省成本。